Literature DB >> 21945379

Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.

Sonja I Gerber1, Ute J Krienke, Nane-Christine Biedermann, Heinz Grunze, Robert H Yolken, Sandra Dittmann, Jens M Langosch.   

Abstract

There is a possible association between infectious agents and psychiatric disorders. Previous studies in the US provided evidence for cognitive impairment correlated with Herpes simplex virus type 1 (HSV-1) infection. For a replication study in Europe we chosed individuals diagnosed with bipolar disorder to analyse the correlation with HSV-1 infection. Antibody prevalence was analyzed by using solid phase immunoassay techniques. Cognitive functioning was tested with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Form A, the Trail Making Test A&B, and two subtests from the WAIS III: the Letter Number Sequencing Task and the subtest on information. History and psychopathology was assessed using structured interviews and validated rating scales (SCID, HRSD-21, YMRS, PANSS). Additionally, we investigated social functioning and quality of life using self-assessment-scales (SAS, LQLP). Prevalence rates of antibodies against diverse infectious agents did not differ significantly between patients and controls. We found a significant correlation between cognitive impairment in patients with bipolar disorder and the prevalence of antibodies directed against HSV-1. Cognitive functions were significantly impaired including language, attention, and immediate memory. The results of this study confirm previous findings suggesting that HSV-1 affects cognitive functions in patients with bipolar disorder. This may also result in more impaired functioning, less quality of life and difficulties in social adjustment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945379     DOI: 10.1016/j.pnpbp.2011.09.003

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  9 in total

1.  Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.

Authors:  Kara D Tarter; Amanda M Simanek; Jennifer B Dowd; Allison E Aiello
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

2.  Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays.

Authors:  Po-Chung Chen; Guan-Da Syu; Kuo-Hsuan Chung; Yu-Hsuan Ho; Feng-Hsiang Chung; Pao-Huan Chen; Jyun-Mu Lin; Yi-Wen Chen; Shang-Ying Tsai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2014-12-24       Impact factor: 5.911

3.  Infection with Herpes Simplex virus type 1 (HSV-1) and sleep: The dog that did not bark.

Authors:  Kyrillos M Meshreky; Joel Wood; Kodavali V Chowdari; Martica H Hall; Kristine A Wilckens; Robert Yolken; Daniel J Buysse; Vishwajit L Nimgaonkar
Journal:  Psychiatry Res       Date:  2019-07-31       Impact factor: 3.222

Review 4.  Epidemiology and risk factors for bipolar disorder.

Authors:  Tobias A Rowland; Steven Marwaha
Journal:  Ther Adv Psychopharmacol       Date:  2018-04-26

5.  Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Hans C Klein; Hester E Duivis; Robert H Yolken; Judith G M Rosmalen; Robert A Schoevers
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

Review 6.  Infectious and immunogenetic factors in bipolar disorder.

Authors:  J Oliveira; A J Oliveira-Maia; R Tamouza; A S Brown; M Leboyer
Journal:  Acta Psychiatr Scand       Date:  2017-08-20       Impact factor: 6.392

7.  The association between antibodies to neurotropic pathogens and bipolar disorder : A study in the Dutch Bipolar (DB) Cohort and meta-analysis.

Authors:  Gijsje J L J Snijders; Hans C van Mierlo; Marco P Boks; Marieke J H Begemann; Arjen L Sutterland; Manja Litjens; Roel A Ophoff; René S Kahn; Lot D de Witte
Journal:  Transl Psychiatry       Date:  2019-11-20       Impact factor: 6.222

8.  Association between decreased HDL levels and cognitive deficits in patients with bipolar disorder: a pilot study.

Authors:  Li Hui; Xiao Li Yin; Jie Chen; Xu Yuan Yin; Hong Liang Zhu; Jin Li; Guang Zhong Yin; Xiao Wen Xu; Xiao Nan Yang; Zheng Kang Qian; Cai Xia Jiang; Zhen Tang; Hai Bing Yang; Eric F C Cheung; Raymond C K Chan; Qiu Fang Jia
Journal:  Int J Bipolar Disord       Date:  2019-11-25

9.  Active HHV-6 Infection of Cerebellar Purkinje Cells in Mood Disorders.

Authors:  Bhupesh K Prusty; Nitish Gulve; Sheila Govind; Gerhard R F Krueger; Julia Feichtinger; Lee Larcombe; Richard Aspinall; Dharam V Ablashi; Carla T Toro
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.